Year: 2023
Type: article
Abstract: Significance: This third biennial intraoperative molecular imaging (IMI) conference shows how optical contrast agents have been applied to develop clinically significant endpoints that improve precision cancer surgery. Aim: National and international experts on IMI presented ongoing clinical trials in cancer surgery and preclinical work. Previously known dyes (with broader applications), new dyes, novel nonfluorescence-based imaging techniques, pediatric dyes, and normal tissue dyes were discussed. Approach: Principal investigators presenting at the Perelman School of Medicine Abramson Cancer Center's third clinical trials update on IMI were selected to discuss their clinical trials and endpoints. Results: Dyes that are FDA-approved or currently under clinical investigation in phase 1, 2, and 3 trials were discussed. Sections on how to move benchwork research to the bedside were also included. There was also a dedicated section for pediatric dyes and nonfluorescence-based dyes that have been newly developed. Conclusions: IMI is a valuable adjunct in precision cancer surgery and has broad applications in multiple subspecialties. It has been reliably used to alter the surgical course of patients and in clinical decision making. There remain gaps in the utilization of IMI in certain subspecialties and potential for developing newer and improved dyes and imaging techniques.
Source: Journal of Biomedical Optics
Authors: Patrick Bou-Samra, Najib Muhammad, Austin Chang, Ritesh Karsalia, Feredun Azari, Gregory Kennedy, Walter Stummer, Janos Tanyi, Linda Martin, Alexander Vahrmeijer, Barbara Smith, Eben Rosenthal, Patrick Wagner, David Rice, Amy Lee, Hafeez Abdelhafeez, Marcus M. Malek, Gary Kohanbash, Wilson Barry Edwards, Eric Henderson, Jane Skjøth-Rasmussen, Ryan Orosco, Summer Gibbs, Richard W. Farnam, Lalitha Shankar, Baran Sumer, Anand T. N. Kumar, Laura Marcu, Lei Li, Viktor Greuv, Edward J. Delikatny, John Y. K. Lee, Sunil Singhal
Institutions: University of Pennsylvania, University of Münster, University Hospital Münster, University of Virginia, Leiden University, Leiden University Medical Center, Harvard University, Stanford Medicine, Stanford University, Allegheny Health Network, The University of Texas MD Anderson Cancer Center, The University of Texas Southwestern Medical Center, Seattle Children's Hospital, St. Jude Children's Research Hospital, Children's Hospital of Pittsburgh, University of Pittsburgh, University of Pittsburgh Medical Center, University of Missouri, Dartmouth College, Dartmouth–Hitchcock Medical Center, University of Copenhagen, University of New Mexico, University of New Mexico Health Sciences Center, Oregon Health & Science University, OHSU Knight Cancer Institute, National Institutes of Health, National Cancer Institute, University of California, Davis, California Institute of Technology, University of Illinois Urbana-Champaign, University of Illinois System
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,675
OpenAlex ID: W4376503549